The molecular control of angiogenesis

International Reviews of Immunology

Volumn 21, Issue 1, 2002, Pages 33-49

  Distler, Oliver ^a   Neidhart, Michel ^a   Gay, Renate E ^a   Gay, Steffen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Angiogenesis; Angiopoietin; Angiostatin; MMP; PDGF; VEGF

Indexed keywords

ANIMAL; BLOOD VESSELS; CELL DIVISION; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; GELATINASE A; HUMAN; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PERMEABILITY; PLASMINOGEN; SUPPORT, NON-U.S. GOV'T; VASODILATION; ANGIOSTATINS; ANIMALS; HUMANS; MATRIX METALLOPROTEINASE 2;

ANGIOSTATIN; GELATINASE A; PEPTIDE FRAGMENT; PLASMINOGEN;

ANGIOGENESIS; ANIMAL; BLOOD VESSEL; CELL DIVISION; CYTOLOGY; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; PERMEABILITY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0035987007     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180210415     Document Type: Article

References (79)

1. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia
2. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice
3. The role of angiogenesis in rheumatoid arthritis: Recent developments
4. Angioneogenesis in rheumatoid arthritis
5. Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis
6. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis
7. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis
8. Systemic sclerosis. A vascular perspective
9. Expression and regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) in systemic sclerosis
10. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95
11. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma
12. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells
13. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors
14. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization
15. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells
16. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculo-genesis in physiological and pathological neovascularization
17. Mechanisms of angiogenesis and arteriogenesis
18. Vascular-specific growth factors and blood vessel formation
19. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
20. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
21. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels
22. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
23. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability
24. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
25. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
26. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
27. Reviewi Angiogenesis: Implications for rheumatoid arthritis
28. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
29. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
30. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
31. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
32. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression
33. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
34. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
35. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
36. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
37. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
38. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
39. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (flk1) and VEGF receptor 3 (flt4)
40. Current biology of VEGF-B and VEGF-C
41. Vascular endothelial growth factor C induces angiogenesis in vivo
42. C-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
43. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane
44. Transforming growth factor-beta inhibits endothelial cell proliferation
45. PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors
46. Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects
47. Fibroblast growth factor-1 stimulates branching and survival of myocardial arteries: A goal for therapeutic angiogenesis?
48. Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice
49. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
50. CXC chemokines in angiogenesis
51. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action
52. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR(+) CXC chemokine-induced angiogenic activity
53. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis
54. Multiple forms of angiostatin induce apoptosis in endothelial cells
55. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
56. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD
57. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance
58. Matrix metalloproteinases generate angiostatin: Effects on neovascularization
59. Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization
60. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
61. Secreted cathepsin L generates endostatin from collagen XVIII
62. The generation of endostatin is mediated by elastase
63. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase
64. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v. beta 3
65. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization
66. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
67. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
68. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
69. Increased vascularization in mice overexpressing angiopoietin-1
70. Angiopoietin-1 protects the adult vasculature against plasma leakage
71. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor
72. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
73. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
74. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
75. Defective angiogenesis in mice lacking endoglin
76. Angiogenesis in ischemic disease
77. Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary
78. Anticancer drug targets: Approaching angiogenesis
79. Angiogenesis in cancer and other diseases